Ibrutinib and Ixazomib Citrate in Treating Newly Diagnosed, Relapsed or Refractory Waldenstrom Macroglobulinemia
Clinical trial NCT03506373 · TERMINATED
Trial details
- NCT number
- NCT03506373
- Sponsor
- Mayo Clinic
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-14
- Primary completion
- 2023-02-06
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.